Microtubule-targeted agents: when mitochondria become essential to chemotherapy

Area of Science:

• Oncology
• Cell Biology
• Pharmacology

Background:

• Microtubule-targeting agents (MTAs) are crucial in cancer chemotherapy, inducing cell death through suppressed microtubule dynamics and the mitochondrial intrinsic pathway.
• The precise molecular links between microtubule network disruption and mitochondrial apoptotic signaling by MTAs remain incompletely understood.

Purpose of the Study:

• To elucidate the essential role of mitochondria in the efficacy of anticancer chemotherapy targeting the microtubule cytoskeleton.
• To explore molecular mechanisms connecting microtubule alterations to mitochondrial apoptotic control and MTA-induced neurotoxicity.

Main Methods:

• Literature review of molecular candidates linking microtubule dynamics and mitochondrial pathways.
• Analysis of evidence on direct mitochondrial targeting by MTAs.
• Synthesis of current concepts on mitochondria-microtubule interplay in MTA neurotoxicity.

Main Results:

• Identified key molecular players mediating the crosstalk between microtubule alterations and mitochondrial apoptotic signaling.
• Discussed the potential of direct mitochondrial targeting to enhance MTA efficacy.
• Highlighted the shared involvement of mitochondria and microtubules in MTA-related neurotoxic side effects.

Conclusions:

• Deciphering the intricate relationship between mitochondrial and microtubule networks is crucial for optimizing cancer chemotherapy response.
• Further research into these interconnections may lead to improved therapeutic strategies and reduced adverse effects.